ID   ROBO3_HUMAN             Reviewed;        1386 AA.
AC   Q96MS0;
DT   21-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   21-JUN-2004, sequence version 2.
DT   07-APR-2021, entry version 165.
DE   RecName: Full=Roundabout homolog 3;
DE   AltName: Full=Roundabout-like protein 3;
DE   Flags: Precursor;
GN   Name=ROBO3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND VARIANTS HGPPS1
RP   PRO-5; LEU-66; LYS-319; GLU-361; PRO-703 AND PRO-705.
RX   PubMed=15105459; DOI=10.1126/science.1096437;
RA   Jen J.C., Chan W.-M., Bosley T.M., Wan J.-J., Carr J.R., Rueb U.,
RA   Shattuck D., Salamon G., Kudo L.C., Ou J., Lin D.D.M., Salih M.A.M.,
RA   Kansu T., Al Dhalaan H., Al-Zayed Z., MacDonald D.B., Stigsby B.,
RA   Plaitakis A., Dretakis E.K., Gottlob I., Pieh C., Traboulsi E.I., Wang Q.,
RA   Wang L., Andrews C., Yamada K., Demer J.L., Karim S., Alger J.R.,
RA   Geschwind D.H., Deller T., Sicotte N.L., Nelson S.F., Baloh R.W.,
RA   Engle E.C.;
RT   "Mutations in a human ROBO gene disrupt hindbrain axon pathway crossing and
RT   morphogenesis.";
RL   Science 304:1509-1513(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANTS MET-423
RP   AND LEU-868.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1263, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
CC   -!- FUNCTION: Thought to be involved during neural development in axonal
CC       navigation at the ventral midline of the neural tube (By similarity).
CC       In spinal chord development plays a role in guiding commissural axons
CC       probably by preventing premature sensitivity to Slit proteins thus
CC       inhibiting Slit signaling through ROBO1 (By similarity). Required for
CC       hindbrain axon midline crossing (PubMed:15105459).
CC       {ECO:0000250|UniProtKB:Q9Z2I4, ECO:0000269|PubMed:15105459}.
CC   -!- SUBUNIT: Probably interacts with SLIT2. {ECO:0000250|UniProtKB:Q9Z2I4}.
CC   -!- INTERACTION:
CC       Q96MS0; Q99435-1: NELL2; NbExp=3; IntAct=EBI-1220465, EBI-16185191;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q9Z2I4}; Single-
CC       pass type I membrane protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96MS0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96MS0-2; Sequence=VSP_010650, VSP_010651;
CC   -!- DISEASE: Gaze palsy, familial horizontal, with progressive scoliosis, 1
CC       (HGPPS1) [MIM:607313]: An autosomal recessive neurologic disorder
CC       characterized by eye movement abnormalities apparent from birth,
CC       childhood-onset progressive scoliosis, distinctive brainstem
CC       malformation and defective crossing of some brainstem neuronal
CC       pathways. {ECO:0000269|PubMed:15105459}. Note=The disease is caused by
CC       variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the immunoglobulin superfamily. ROBO family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY509035; AAS91662.1; -; mRNA.
DR   EMBL; AK056544; BAB71212.1; -; mRNA.
DR   CCDS; CCDS44755.1; -. [Q96MS0-1]
DR   RefSeq; NP_071765.2; NM_022370.3. [Q96MS0-1]
DR   PDB; 6POG; X-ray; 2.75 A; A=551-663.
DR   PDB; 6POK; X-ray; 1.80 A; A=664-870.
DR   PDB; 6POL; X-ray; 1.80 A; A/C/E=549-652.
DR   PDBsum; 6POG; -.
DR   PDBsum; 6POK; -.
DR   PDBsum; 6POL; -.
DR   SMR; Q96MS0; -.
DR   BioGRID; 122111; 11.
DR   DIP; DIP-38410N; -.
DR   IntAct; Q96MS0; 2.
DR   STRING; 9606.ENSP00000380903; -.
DR   GlyGen; Q96MS0; 11 sites.
DR   iPTMnet; Q96MS0; -.
DR   PhosphoSitePlus; Q96MS0; -.
DR   BioMuta; ROBO3; -.
DR   DMDM; 49036492; -.
DR   EPD; Q96MS0; -.
DR   jPOST; Q96MS0; -.
DR   MassIVE; Q96MS0; -.
DR   MaxQB; Q96MS0; -.
DR   PaxDb; Q96MS0; -.
DR   PeptideAtlas; Q96MS0; -.
DR   PRIDE; Q96MS0; -.
DR   ProteomicsDB; 77392; -. [Q96MS0-1]
DR   ProteomicsDB; 77393; -. [Q96MS0-2]
DR   Antibodypedia; 2550; 194 antibodies.
DR   DNASU; 64221; -.
DR   Ensembl; ENST00000397801; ENSP00000380903; ENSG00000154134. [Q96MS0-1]
DR   GeneID; 64221; -.
DR   KEGG; hsa:64221; -.
DR   UCSC; uc001qbc.4; human. [Q96MS0-1]
DR   CTD; 64221; -.
DR   DisGeNET; 64221; -.
DR   GeneCards; ROBO3; -.
DR   HGNC; HGNC:13433; ROBO3.
DR   HPA; ENSG00000154134; Tissue enhanced (epididymis).
DR   MalaCards; ROBO3; -.
DR   MIM; 607313; phenotype.
DR   MIM; 608630; gene.
DR   neXtProt; NX_Q96MS0; -.
DR   OpenTargets; ENSG00000154134; -.
DR   Orphanet; 2744; Horizontal gaze palsy with progressive scoliosis.
DR   PharmGKB; PA134896648; -.
DR   VEuPathDB; HostDB:ENSG00000154134.14; -.
DR   eggNOG; KOG4222; Eukaryota.
DR   GeneTree; ENSGT00940000155457; -.
DR   HOGENOM; CLU_003227_5_1_1; -.
DR   InParanoid; Q96MS0; -.
DR   OMA; GKAVQMP; -.
DR   OrthoDB; 173520at2759; -.
DR   PhylomeDB; Q96MS0; -.
DR   TreeFam; TF351053; -.
DR   PathwayCommons; Q96MS0; -.
DR   Reactome; R-HSA-428542; Regulation of commissural axon pathfinding by SLIT and ROBO. [Q96MS0-1]
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs. [Q96MS0-1]
DR   Reactome; R-HSA-9010642; ROBO receptors bind AKAP5. [Q96MS0-1]
DR   BioGRID-ORCS; 64221; 2 hits in 988 CRISPR screens.
DR   ChiTaRS; ROBO3; human.
DR   GeneWiki; ROBO3; -.
DR   GenomeRNAi; 64221; -.
DR   Pharos; Q96MS0; Tbio.
DR   PRO; PR:Q96MS0; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q96MS0; protein.
DR   Bgee; ENSG00000154134; Expressed in left ovary and 211 other tissues.
DR   ExpressionAtlas; Q96MS0; baseline and differential.
DR   Genevisible; Q96MS0; HS.
DR   GO; GO:0030424; C:axon; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0098632; F:cell-cell adhesion mediator activity; IBA:GO_Central.
DR   GO; GO:0007411; P:axon guidance; ISS:UniProtKB.
DR   GO; GO:0016199; P:axon midline choice point recognition; ISS:UniProtKB.
DR   GO; GO:0061642; P:chemoattraction of axon; IEA:Ensembl.
DR   GO; GO:0071679; P:commissural neuron axon guidance; IEA:Ensembl.
DR   GO; GO:0070593; P:dendrite self-avoidance; IBA:GO_Central.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IBA:GO_Central.
DR   CDD; cd00063; FN3; 3.
DR   Gene3D; 2.60.40.10; -; 8.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR032987; Robo3.
DR   PANTHER; PTHR12231:SF236; PTHR12231:SF236; 1.
DR   Pfam; PF00041; fn3; 3.
DR   Pfam; PF07679; I-set; 3.
DR   SMART; SM00060; FN3; 3.
DR   SMART; SM00409; IG; 5.
DR   SMART; SM00408; IGc2; 5.
DR   SUPFAM; SSF48726; SSF48726; 5.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   PROSITE; PS50853; FN3; 3.
DR   PROSITE; PS50835; IG_LIKE; 5.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chemotaxis; Developmental protein;
KW   Differentiation; Disease variant; Disulfide bond; Glycoprotein;
KW   Immunoglobulin domain; Membrane; Neurogenesis; Phosphoprotein; Receptor;
KW   Reference proteome; Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000255"
FT   CHAIN           21..1386
FT                   /note="Roundabout homolog 3"
FT                   /id="PRO_0000031038"
FT   TOPO_DOM        21..891
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        892..912
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        913..1386
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          64..160
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          166..253
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          258..342
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          347..440
FT                   /note="Ig-like C2-type 4"
FT   DOMAIN          450..531
FT                   /note="Ig-like C2-type 5"
FT   DOMAIN          558..652
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          671..766
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          771..869
FT                   /note="Fibronectin type-III 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   MOD_RES         1263
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   CARBOHYD        25
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        34
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        41
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        53
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        156
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        410
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        459
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        503
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        784
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        813
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        820
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        85..143
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        187..236
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        279..326
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        368..424
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        472..521
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         1025..1034
FT                   /note="AGEELQTFHG -> LTTPLLILTT (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_010650"
FT   VAR_SEQ         1035..1386
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_010651"
FT   VARIANT         5
FT                   /note="L -> P (in HGPPS1; dbSNP:rs121918275)"
FT                   /evidence="ECO:0000269|PubMed:15105459"
FT                   /id="VAR_019119"
FT   VARIANT         66
FT                   /note="I -> L (in HGPPS1; dbSNP:rs121918276)"
FT                   /evidence="ECO:0000269|PubMed:15105459"
FT                   /id="VAR_019120"
FT   VARIANT         319
FT                   /note="E -> K (in HGPPS1; dbSNP:rs121918274)"
FT                   /evidence="ECO:0000269|PubMed:15105459"
FT                   /id="VAR_019073"
FT   VARIANT         361
FT                   /note="G -> E (in HGPPS1; dbSNP:rs121918270)"
FT                   /evidence="ECO:0000269|PubMed:15105459"
FT                   /id="VAR_019121"
FT   VARIANT         416
FT                   /note="R -> H (in dbSNP:rs3862618)"
FT                   /id="VAR_053642"
FT   VARIANT         423
FT                   /note="V -> M (in dbSNP:rs4935898)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_034474"
FT   VARIANT         703
FT                   /note="R -> P (in HGPPS1; dbSNP:rs121918271)"
FT                   /evidence="ECO:0000269|PubMed:15105459"
FT                   /id="VAR_019074"
FT   VARIANT         705
FT                   /note="S -> P (in HGPPS1; dbSNP:rs121918272)"
FT                   /evidence="ECO:0000269|PubMed:15105459"
FT                   /id="VAR_019075"
FT   VARIANT         868
FT                   /note="P -> L (in dbSNP:rs55706177)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_062145"
FT   VARIANT         1369
FT                   /note="Q -> R (in dbSNP:rs35723495)"
FT                   /id="VAR_034475"
FT   STRAND          563..567
FT                   /evidence="ECO:0007744|PDB:6POL"
FT   STRAND          572..575
FT                   /evidence="ECO:0007744|PDB:6POL"
FT   STRAND          588..594
FT                   /evidence="ECO:0007744|PDB:6POL"
FT   TURN            596..598
FT                   /evidence="ECO:0007744|PDB:6POG"
FT   STRAND          603..609
FT                   /evidence="ECO:0007744|PDB:6POL"
FT   STRAND          611..616
FT                   /evidence="ECO:0007744|PDB:6POL"
FT   STRAND          624..633
FT                   /evidence="ECO:0007744|PDB:6POL"
FT   STRAND          672..675
FT                   /evidence="ECO:0007744|PDB:6POK"
FT   STRAND          686..694
FT                   /evidence="ECO:0007744|PDB:6POK"
FT   HELIX           696..698
FT                   /evidence="ECO:0007744|PDB:6POK"
FT   STRAND          701..708
FT                   /evidence="ECO:0007744|PDB:6POK"
FT   STRAND          717..721
FT                   /evidence="ECO:0007744|PDB:6POK"
FT   STRAND          728..731
FT                   /evidence="ECO:0007744|PDB:6POK"
FT   STRAND          738..747
FT                   /evidence="ECO:0007744|PDB:6POK"
FT   STRAND          759..762
FT                   /evidence="ECO:0007744|PDB:6POK"
FT   STRAND          773..779
FT                   /evidence="ECO:0007744|PDB:6POK"
FT   STRAND          782..785
FT                   /evidence="ECO:0007744|PDB:6POK"
FT   STRAND          787..792
FT                   /evidence="ECO:0007744|PDB:6POK"
FT   HELIX           796..799
FT                   /evidence="ECO:0007744|PDB:6POK"
FT   STRAND          805..811
FT                   /evidence="ECO:0007744|PDB:6POK"
FT   HELIX           815..817
FT                   /evidence="ECO:0007744|PDB:6POK"
FT   STRAND          819..824
FT                   /evidence="ECO:0007744|PDB:6POK"
FT   STRAND          829..832
FT                   /evidence="ECO:0007744|PDB:6POK"
FT   STRAND          840..849
FT                   /evidence="ECO:0007744|PDB:6POK"
FT   STRAND          852..856
FT                   /evidence="ECO:0007744|PDB:6POK"
FT   STRAND          860..863
FT                   /evidence="ECO:0007744|PDB:6POK"
SQ   SEQUENCE   1386 AA;  148209 MW;  955A7300A2BDA27F CRC64;
     MLRYLLKTLL QMNLFADSLA GDISNSSELL LGFNSSLAAL NHTLLPPGDP SLNGSRVGPE
     DAMPRIVEQP PDLLVSRGEP ATLPCRAEGR PRPNIEWYKN GARVATVRED PRAHRLLLPS
     GALFFPRIVH GRRARPDEGV YTCVARNYLG AAASRNASLE VAVLRDDFRQ SPGNVVVAVG
     EPAVLECVPP RGHPEPSVSW RKDGARLKEE EGRITIRGGK LMMSHTLKSD AGMYVCVASN
     MAGERESAAA EVMVLERPSF LRRPVNQVVL ADAPVTFLCE VKGDPPPRLR WRKEDGELPT
     GRYEIRSDHS LWIGHVSAED EGTYTCVAEN SVGRAEASGS LSVHVPPQLV TQPQDQMAAP
     GESVAFQCET KGNPPPAIFW QKEGSQVLLF PSQSLQPTGR FSVSPRGQLN ITAVQRGDAG
     YYVCQAVSVA GSILAKALLE IKGASLDGLP PVILQGPANQ TLVLGSSVWL PCRVTGNPQP
     SVRWKKDGQW LQGDDLQFKT MANGTLYIAN VQEMDMGFYS CVAKSSTGEA TWSGWLKMRE
     DWGVSPDPPT EPSSPPGAPS QPVVTEITKN SITLTWKPNP QTGAAVTSYV IEAFSPAAGN
     TWRTVADGVQ LETHTVSGLQ PNTIYLFLVR AVGAWGLSEP SPVSEPVRTQ DSSPSRPVED
     PWRGQQGLAE VAVRLQEPIV LGPRTLQVSW TVDGPVQLVQ GFRVSWRVAG PEGGSWTMLD
     LQSPSQQSTV LRGLPPGTQI QIKVQAQGQE GLGAESLSVT RSIPEEAPSG PPQGVAVALG
     GDGNSSITVS WEPPLPSQQN GVITEYQIWC LGNESRFHLN RSAAGWARSA MLRGLVPGLL
     YRTLVAAATS AGVGVPSAPV LVQLPSPPDL EPGLEVGAGL AVRLARVLRE PAFLAGSGAA
     CGALLLGLCA ALYWRRKQRK ELSHYTASFA YTPAVSFPHS EGLSGASSRP PMGLGPAPYS
     WLADSWPHPS RSPSAQEPRG SCCPSNPDPD DRYYNEAGIS LYLAQTARGT AAPGEGPVYS
     TIDPAGEELQ TFHGGFPQHP SGDLGPWSQY APPEWSQGDS GAKGGKVKLL GKPVQMPSLN
     WPEALPPPPP SCELSCLEGP EEELEGSSEP EEWCPPMPER SHLTEPSSSG GCLVTPSRRE
     TPSPTPSYGQ QSTATLTPSP PDPPQPPTDM PHLHQMPRRV PLGPSSPLSV SQPMLGIREA
     RPAGLGAGPA ASPHLSPSPA PSTASSAPGR TWQGNGEMTP PLQGPRARFR KKPKALPYRR
     ENSPGDLPPP PLPPPEEEAS WALELRAAGS MSSLERERSG ERKAVQAVPL AAQRVLHPDE
     EAWLPYSRPS FLSRGQGTST CSTAGSNSSR GSSSSRGSRG PGRSRSRSQS RSQSQRPGQK
     RREEPR
//
